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Abstract
Background: We describe an ELISA-based method that can be used to identify and quantitate
proteins in biological samples. In this method, peptides in solution, derived from proteolytic digests
of the sample, compete with substrate-attached synthetic peptides for antibodies, also in solution,
generated against the chosen peptides. The peptides used for the ELISA are chosen on the basis of
their being (i) products of the proteolytic (e.g. tryptic) digestion of the protein to be identified and
(ii) unique to the target protein, as far as one can know from the published sequences.
Results: In this paper we describe the competition assay and we define the optimal conditions for
the most effective assay. We have performed an analysis of the kinetics of interaction between the
four components of the assay: the plastic substratum to which the peptide is bound, the bound
peptide itself, the competing added peptide, and the antibody that is specific for the peptide and we
compare the results of theoretical simulations to the actual data in some model systems.
Conclusion: The data suggest that the peptides bind to the plastic substratum in more than one
conformation and that, once bound, the peptide displays different affinities for the antibody,
depending on how it has bound to the plate
Background
We have developed the Peptidomatrix, a method for the
quantitative analysis of proteins in biological samples.
The method's main thrust is that peptides, derived from
proteolytic digestion of all the proteins in the sample,
rather than the proteins themselves, are assayed. The assay
is a competition ELISA and in order to obtain quantitative
data a calibration curve with synthetic peptides is run in
every experiment. In a related paper (Braitbard et al., sub-
mitted) we present the application of Peptidomatrix to
the detection of four membrane proteins in cell culture
and human lymphocytes.
Here we present a study of the kinetics of interaction
between the four components of the Peptidomatrix: (1)
The plastic substratum to which the peptide is bound; (2)
the bound peptide itself; (3) the competing added pep-
tide; and (4) the antibody that is specific for the peptide
[1,2].
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There have been very many studies, both experimental
and theoretical, of ELISA assays using antibody-peptide
interactions. In the majority of these studies the antibod-
ies themselves are bound to the plastic substratum [1-13].
These papers had aims that were somewhat different from
those with which we are concerned. Some studied the
influence of the length of the epitope on the affinity [5],
others the ability to design vaccine according to the nature
of the peptide [6], the identification of antibodies in sera
[7] or understanding the structure of the subunit of the
protein [8]. We have been able to find very few examples
in which a peptide antigen is bound to the solid support.
[2,9-11]. Again, these papers concern themselves with
issues such as the chemical nature of the binding reaction,
[11], which are not coincident with ours, and in none of
these is a full theoretical treatment presented. Other stud-
ies involve the use of the BIAcore technology [2,10] and,
although very interesting in themselves, do not help us
directly in our studies that use a plastic culture dish sub-
stratum. We have attempted to fill this gap as far as we are
able.
To understand the interaction between the various com-
ponents of our competitive ELISA, one should note that
what we are concerned with is not the intrinsic affinity
between ligand and antibody but, instead, the avidity.
Affinity is the measure of the intrinsic strength of the
binding of an epitope to an antibody. Avidity is the oper-
ational measure of the overall stability of the complex
between antibody and antigen and this is governed by
three major factors: (1) The intrinsic affinity of the anti-
body for the epitope; (2) the valency of the combination
between antibody and antigen and (3) the geometric
arrangement of the interacting components [12].
To calculate the avidities in our competitive ELISA system
we have to consider the kinetics of interaction between
the four components of the assay: the plastic substratum
to which the peptide is bound, the bound peptide itself,
the competing added peptide, and the antibody that is
specific for the peptide.
The special structures of the peptides and the different
possibilities by which they become bound to the plastic
substratum influence the avidity, and distinguish it from
other antigens such as whole proteins or peptides that are
bound to a carrier.
Binding between antibodies and their specific polypep-
tide ligands is conventionally analyzed in terms of opera-
tionally measured, hyperbolic binding isotherms. Binding
between molecules and the plastic substratum of ELISA
plates is likewise analyzed in general in terms of adsorp-
tion isotherms. We combined these two approaches and
set up models in which the adsorption to the plate is a
simple isotherm or a more complex one. Comparison
with the experimental data suggests that the peptides bind
to the plastic substratum with more than one modality
and that, once bound, the peptide displays different affin-
ities for the antibody depending on how it is bound to the
plate.
Results
The Peptidomatrix assay uses peptides that are chosen as
being (i) specific for a target protein and (ii) amongst the
products of tryptic digestion of that protein. We subjected
the membrane protein transporters MXR (or BCRP i.e.
ABCG2) and MRP1 (ABCC1), and the alpha chain of
Na,K_ATPase (ATP1A1) to a virtual tryptic digestion and
selected all the peptides of length 7 to 15 amino-acids.
Each one of these peptides was analyzed using the BLAST
program (see methods). The desirable peptide contains
only matches that are 5 amino acids or shorter, and a min-
imal number of them. The peptides chosen are listed in
Table 1.
The Peptidomatrix assay, as described in the Introduction,
is a competition assay (Figure 1) :Peptides are bound to
plastic wells. Antibodies specific to the peptide are then
added in solution and allowed to bind to the attached
peptide in the presence or the absence of a sample digest.
A calibration curve is generated in parallel with known
quantities of free synthetic peptide. The concentration of
soluble peptide in the sample is then measured by inter-
polation.
The assay will be most sensitive when the added peptide
blocks the reaction between antibody and bound peptide
at the lowest possible concentration. On the other hand,
we need to obtain the highest possible signal-to-noise
ratio in the final ELISA assay. To explore the optimal con-
ditions for this, we performed a series of experiments in
which we varied the amount of bound peptide and the
concentration of antibody, before performing the compe-
tition with added peptide.
Fig 2A depicts the binding of polyclonal antibodies
(raised against the peptide MXR P2), at four different dilu-
tions, to peptide MXR P2 bound to the wells of the ELISA
plate at increasing concentrations. The bound antibodies
are detected by a secondary antibody (anti-rabbit IgG)
conjugated to horseradish peroxidase. In Fig 3A, the same
manipulations are performed with peptide MXR P3. In
each case, the ELISA signal reaches a plateau as the
amount of bound peptide is increased; the maximum size
of the signal increases with increasing amount of anti-
body. The data were fitted (using Sigmaplot) to Equation
1 of Materials and Methods, a conventional hyperbolic
isotherm, yielding the parameters of Amax (the maximum
signal) and Kd (the concentration of bound peptide atProteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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which half the maximal increase in signal was obtained),
together with a parameter D that represents the signal in
the absence of bound peptide. Adding pre-immune serum
at the highest concentration gave essentially no increase in
signal above background (figs 2A). Figs 2B and 3B depict
the signals obtained when we added increasing amounts
of the relevant antibody at different fixed amounts of
bound peptides MXR P2 and MXR P3. Again, the data for
all these figures were fitted using Equation 1 of Materials
and Methods, with the kinetic parameters listed in Table
2.
Figs 2C and 3C depict competition assays presented as the
signals obtained when we chose a single concentration of
added antibody and titrated it with increasing concentra-
tions of added free peptide, at two concentrations of
bound peptide in Fig 2 but at a single concentration in Fig
3, with the addition of a titration using a non-related pep-
tide depicted in Fig 3C.
Figure 4 depicts an analysis of the Peptidomatrix condi-
tions for the detection of the Na,K-ATPase. Panels A and C
show a titration using increasing concentrations of bound
peptides ATP P1 and ATP P3, at two different concentra-
tions of antibody. The parameters obtained by curve fit-
ting of these data are recorded in Table 3. Panels B and D
of Fig 4 depict inhibition curves, as in figures 2C and 3C,
using the peptides chosen for the Na,K-ATPase, at differ-
ent concentrations of the appropriate antibody, with
parameters recorded in Table 3.
Inspection of these figures and Tables shows that the
received signal increases with increasing concentrations of
either the bound peptide or the appropriate antibody
until it reaches a plateau. Comparing the binding curves
at increasing amounts of bound peptide or increasing
concentrations of antibody we see that the derived Amax,
the overall amplitude of the signal, increases accordingly.
All this is expected, since increasing either the amount of
binding sites or the concentration of the free ligand will
increase the signal, until a maximum, and therefore satu-
ration, is reached.
With regard to the inhibition (that is, competition) curves
there is a similar trend, with Amax (the signal in the
absence of externally added peptide) again increasing as
The procedure of the 'Peptidomatrix' assay Figure 1
The procedure of the 'Peptidomatrix' assay. The 
ELISA Peptidomatrix is a competition assay: Peptides are 
bound to the plastic wells and they are subsequently exposed 
to antibodies generated against them. A labeled secondary 
antibody is used to detect the bound primary antibodies. In 
the assay itself the antibodies are mixed with soluble syn-
thetic peptide in known amounts, to generate a calibration 
curve. The peptide in solution competes with the bound pep-
tide and will affect the signal. As shown schematically in the 
figure: Panel A, A': No free peptide is added, thus the signal 
will be the highest. Panel B, B': A small amount of free pep-
tide is added and the signal will be intermediate. Panel C, C': 
A large amount of competing peptide is added, thus no anti-
body binds to the well and the signal is minimal. (see Materi-
als and Methods for details)
A’ C’ B’
A C B
Table 1: Peptides and antibodies used throughout this study. Note that all these peptides have a cysteine at their N terminus, which 
has been added for conjugating them to a carrier protein for the immunization
Peptide name Sequences Location Serum from rabbit
MXR P1 CVGTQFIR 178–184 #65158, #64541
MXR P2 CLAEIYVNSSFYK 332–343 #64795, #64850
MXR P3 CEISYTTSFCHQLR 366–378 #64795, #64850
MXR P4 CLFIHYISGYYR 454–465 #64853, #64851
MXR P5 CNDSTGIQNR 418–426 #64853, #64851
MRP1 P1 CPSDLLQQR 1511–1518 #A0151, #A0152
MRP1 P2 CDLWSLNK 240–246 #A0151, #A0152
NaK ATPase P1 CIPFNSTNK 478–485 #64845, #64846
NaK ATPase P2 CPTTPEWVK 74–81 #64845, #64846
NaK ATPase P3 CTGTLTQNR 368–375 #64855, #64856
NaK ATPase P4 CYEPAAVSE 10–17 #64855, #64856Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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function of either the attached peptide or the concentra-
tion of the antibody. Also this is expected, since Amax is
the expression of the maximal binding of the antibody to
the peptide, when there is no competition.
It is not immediately obvious, however, whether the val-
ues of the half-saturation concentrations, Kd, in the vari-
ous experimental situations, should increase, decrease or
be invariant. Table 4 summarizes the results of all the
experiments using the MXR, ATPase and MRP1 peptides
in terms of the trends of increase or decrease in the values
of Amax and Kd. As expected in all cases, the parameter
Amax increases as either the amount of bound peptide or
of added antibody is increased. However, in most cases in
Columns A (when it is the amount of pre-attached pep-
tide that is continuously varied at fixed amounts of added
antibody) and in Column B (antibody varied at fixed
attached peptide), the Kd parameter decreases as the
amount of bound peptide or of added antibody is raised.
In the case of the competition experiments (where it is the
concentration of free added peptide that is the variable)
Amax again increases with an increase in the amount of
bound peptide or of added antibody, but the Kd value
increases in both the two conditions (Columns C and D).
We attempted to account for these trends in the Amax and
Kd data by devising a theoretical equation the takes into
account the binding of the peptides to the plastic substra-
tum, the binding of the antibody to the bound peptide
and, finally, the interaction between the free peptide and
the antibody in the competition experiments. The deriva-
tion of the appropriate equations is given in the Appen-
dix.
The binding of the antibody to the attached peptide is
described by equation A2
This equation predicts the signal obtained when an
amount P of bound peptide is added to a well having a
maximal binding capacity of cap  and a half-saturation
concentration for this binding of Kp, where the concentra-
tion of added antibody is A, with a half-saturation concen-
tration for the peptide/antibody isotherm of Ka. Fig 5
depicts the predictions of this equation when, in panel A,
the concentration of bound peptide is varied continu-
ously while that of the added antibody is set at different
values. In panel B the antibody concentration varies con-
tinuously while the amount of bound peptide is varied
stepwise. Arbitrary values were assigned to the other con-
stants. These theoretical lines were fitted using equation 1
A oundAb 2 B
cap P
Kp P
A
Ka A
=
∗
+





∗
+
Table 2: Kinetic parameters obtained from the optimization of the Peptidomatrix conditions for peptide MXR P2 and the serum from 
rabbit # 64850 (see Figure 2) (± SD, n = 3).
A : increasing attached peptide at four fixed levels of added antibody
1 stAB Concentration 
0.0005 serum/PBS
1 stAB Concentration 
0.001 serum/PBS
1 stAB Concentration 
0.005 serum/PBS
1 stAB Concentration 0.01 
serum/PBS
Kd (µg/ml) 0.49 ± 0.25 0.89 ± 0.56 0.49 ± 0.097 0.24 ± 0.06
Amax (OD units) 0.076 ± 0.01 0.12 ± 0.01 0.22 ± 0.012 0.35 ± 0.024
D (OD units) 0.29 ± 0.008 0.3 ± 0.015 0.29 ± 0.009 0.3 ± 0.02
B: increasing added antibody at three fixed levels of attached peptide
Attached peptide 0.25 µg/
ml
Attached peptide 0.5 µg/ml Attached peptide 1 µg/ml
Kd (serum dilutions) 0.003 ± 0.0007 0.003 ± 0.001 0.001 ± 0.0002
Amax (OD units) 0.35 ± 0.023 0.56 ± 0.06 0.49 ± 0.02
D (OD units) 0.38 ± 0.01 0.38 ± 0.02 0.38 ± 0.01
C: Competition assay – Kd determined when increasing added free peptide at two fixed levels of attached peptide
Attached peptide 0.25 µg/
ml
Attached peptide 0.5 µg/ml
Kd (µg/ml) 0.14 ± 0.03 0.97 ± 0.15
Amax (OD units) 0.29 ± 0.019 0.37 ± 0.016
D (OD units) 0.39 ± 0.01 0.35 ± 0.01Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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of the Materials and Methods section to obtain the param-
eters listed in sections A and B of Table 5. As expected, the
Amax values increase with an increase in either bound
peptide or added antibody. The Kd values are, however,
invariant under these changes, in contrast to what was
found experimentally. Figs 5C and 5D depict the theoret-
ical predictions of the appropriate equation (equation A5)
for the competition protocol, where it is now free peptide
that is added with the added antibody (at varying concen-
trations of bound peptide and added antibody, Figs 5C
and 5D, respectively).
Where we write   (see the appendix for details).
Fitting these lines to equation 2 of Materials and Methods
yields the parameters listed in sections C and D of Table
5. In both cases, the parameter Amax increases, as found
A oundAb 5
1
Bc o m p
Bp AP Kf
Kf AP F
()
()
=
∗∗
∗+ +
AP
TotA
Ka
=
Determination of the optimal conditions for the Peptidomatrix, using the peptide MXR P2 and the serum from rabbit # 64850 Figure 2
Determination of the optimal conditions for the Peptidomatrix, using the peptide MXR P2 and the serum 
from rabbit # 64850. (A) Binding of the antibody (at different dilutions) to wells containing increasing amounts of peptide. 
The actual amount of bound peptide has not been determined and it is assumed that it is proportional to the concentration 
used for coating the wells. Antibody dilutions: 1:100 (● ), 1:200 (❍ ), 1:1000 (▼ ), 1:2000 (Ќ) and pre-immune serum 1:100 (). 
(B) Titration of bound peptide with increasing concentrations of antibody (expressed as dilutions of the antiserum) 3 concen-
trations of attached peptide (1.0 (● ) 0.5 (❍ ) and 0.25 (▼ ) µg/ml) were used. (C) Competition between attached and free pep-
tide using 2 concentration of attached peptide, 0.5 (● ) and 0.25 (❍ ) µg/ml, antibody dilution was 1:750. All the data were 
analyzed using equations 1 and 2 described in the methods. The, values of KdKd, Amax and D appear in Table 2. All the data 
points represent the average of triplicates.Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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experimentally. The Kd value, however, is again invariant
as the amount of bound peptide is increased (in contrast
to the experimental findings), but increases as the amount
of added antibody increases (as was found experimen-
tally).
In an attempt to resolve the discrepancy between the
experimental data and the model predictions, we ana-
lyzed a more complex model in which the plastic substra-
tum bears at least two classes of sites to which the peptide
can bind. The two classes have different affinities for pep-
tide (Kp1 and Kp2) and the bound peptide then displays a
different affinity for a particular antibody (Ka1 and Ka2).
(We envisage this as depicted in the diagram of Fig 7,
where a peptide is shown as binding at one end only to
the substratum or at both ends, and the antibody can then
bind with a higher or a lower affinity to the peptide.) The
free peptide in the solution binds, of course, with a single
affinity Kf, since it binds to the unbound antibody. The
equations describing this more complex model are equa-
tion A6 for the binding curves and equation A7 for the
competition curves.
A oundAb 6
1
1
2
2
B
cap P
Kp P
A
Ka A
cap P
Kp P
A
Ka A
=
∗
+





∗
+
+
∗
+





∗
+
Determination of the optimal conditions for the Peptidomatrix, using the peptide MXR P3 and the serum from rabbit # 64795 Figure 3
Determination of the optimal conditions for the Peptidomatrix, using the peptide MXR P3 and the serum 
from rabbit # 64795. Panels A, B and C are as described in the legend of Figure 2 except that in panel A there is no pre-
immune serum reaction AND 1:2000, in panel B only two concentrations of attached peptide (0.5 (● ) and 0.25(❍ )) were used 
and in panel C there is only one value of attached peptide (0.5 µg/ml), with the other curve being generated with pre-immune 
serum. The, values of KdKd, Amax and D appear in Table 3. All the data points represent the average of triplicates.Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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The derivation of these equations can be found in the
Appendix. The predictions of the equations are depicted
in Fig 6A and 6B (for equation A6) and C and D (for equa-
tion A7) and recorded in Table 6. As expected, the values
of Amax increase when either the amount of bound pep-
tide or of added antibody increases, but now the value of
Kd falls substantially with an increase in these inputs. This
is the result found experimentally as listed in Table 4. For
the competition protocol, the theoretical predictions are
now of an increase in the half saturation concentration for
added free peptide when either bound peptide or added
antibody is increased. (The effect is small but consistent,
when it is the attached peptide that is varied). This is in
accord with the experimental data, but is in contrast with
the predictions of the simple one-site model, in the case
where it is the attached peptide's concentration that is
increased.
Discussion
We undertook these experiments in order to ascertain
what might be the most optimal conditions for perform-
ing the Peptidomatrix assays. Our aim was to find condi-
tions that would give us the maximum sensitivity (i.e.
enable us to detect the smallest possible amount of target
protein) and yet the highest possible signal-to-noise
A oundAb 7
1
11
1
B competition
cap P
Kp P
TotA
Ka
Kf
Kf
TotA
Ka
()
()
=
∗
+
∗∗
∗+ + +
+
+
∗∗
∗+ + F
cap P
Kp P
TotA
Ka
Kf
Kf
TotA
Ka
F
*
()
22
2
1
Binding of the antibody (at different dilutions) to wells containing increasing amounts of ATPase peptide Figure 4
Binding of the antibody (at different dilutions) to wells containing increasing amounts of ATPase peptide. In 4A 
and 4C a different peptide/antibody combination is shown at two different dilutions of the antibody: (● ) 1:1500; (❍ ) 1:3000. 
Panel A: ATP1/RS64845; panel C ATP3/RS64855. Competition between attached and free peptide is depicted in B and D using 
3 (dilutions of antibody: (1:400 (● ); 1:800 (❍ ); 1:1600 (▼ ). Peptide/antibody combinations are as in A and C, respectively for B 
and D. All the data points represent the average of triplicates.Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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ration. The Peptidomatrix assay is done using the compe-
tition protocol depicted in Fig 1, experimental results with
this protocol being given in Figs 2C, 3C, 4B and 4D and
in the Supplementary materials. It is clear that, both in
theory and in practice, the highest signal-to-noise ratio is
obtained by using plateau values of the bound peptide
and of the added antibody. But are these the conditions
that will give the maximum sensitivity?
Assuming that the peptide binds to the plastic with one
modality and that the bound peptide displays one single
site to the antibody (one-site binding model) we would
predict (Table 5, sections C and D) that the half-saturation
concentration for competition by added free peptide in
the competition assay would be invariant with respect to
amount of bound peptide, but would increase with the
concentration of added antibody. A low Kd in the compe-
tition assay is the condition for maximum sensitivity,
since, in this case, a small amount of externally added
peptide can be detected. Thus, the condition of maximum
attached peptide and a low added antibody would be the
most sensitive situation, yet would give a good signal to
noise ratio. But does this one-site model give a correct
explanation of the data in a real situation? Experimen-
tally, we find that increasing the amount of attached pep-
tide leads to an apparent higher affinity of antibody to this
bound peptide, while increasing the amount of added
antibody again leads to higher apparent affinities for the
attached peptide. This is in contrast to the predictions of
the one site model. Solving the two-site model indeed
leads to predictions that more closely model the real situ-
ation but, happily, still leave us with a similar recommen-
dation for the conditions that give maximum sensitivity
and yet a high signal to noise ratio. Increasing the amount
of pre-attached peptide does now lead to an increase in
the Kd for competition by added peptide, but this increase
Table 3: Kinetic parameters obtained from the optimization of the Peptidomatrix conditions with the peptides and antibodies specific 
to Na/K ATPase (see figure 4) (± SD, n = 3)
A: increasing attached peptide at two fixed levels of added antibody
1 stAB Concentration 0.00033 
serum/PBS
1 stAB Concentration 0.00066 
serum/PBS
Kd (µg/ml) 0.19 ± 0.01 0.1 ± 0.02
Amax (OD units) 1.36 ± 0.02 1.56 ± 0.08
D (OD units) 0.25 ± 0.02 0.38 ± 0.07
B: Competition assay – Kd determined when increasing added free peptide at three fixed levels of added antibody
1 stAB concentration 0.000625 
serum/PBS
1 stAB concentration 
0.000125serum/PBS
1 stAB concentration 0.0025 
serum/PBS
Kd (µg/ml) 0.55 ± 0.1 0.83 ± 0.12 2.55 ± 1.21
Amax (OD units) 1.16 ± 0.05 1.35 ± 0.05 1.33 ± 0.17
D (OD units) 0.59 ± 0.04 0.86 ± 0.04 1.17 ± 0.18
C: increasing attached peptide at two fixed levels of added antibody
1 stAB concentration 0.00033 
serum/PBS
1 stAB concentration 0.00067 
serum/PBS
Kd (serum dilutions) 0.33 ± 0.08 0.29 ± 0.04
Amax (OD units) 1.46 ± 0.09 1.74 ± 0.06
D (OD units) 0.19 ± 0.079 0.24 ± 0.05
D: Competition assay- Kd determined when increasing added free peptide at three fixed levels of added antibody
1 stAB concentration 0.000625 
serum/PBS
1 stAB concentration 0.00125 
serum/PBS
1 stAB concentration 0.0025 
serum/PBS
Kd (µg/ml) 0.68 ± 0.12 0.99 ± 0.19 2.04 ± 0.3
Amax (OD units) 1.58 ± 0.06 1.87 ± 0.09 2.05 ± 0.08
D (OD units) 0.25 ± 0.05 0.25 ± 0.08 0.28 ± 0.08Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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is small. Increasing the amount of added antibody
increases the half-saturation concentration for the free
peptide, and hence decrease the sensitivity of the assay, yet
this effect is smaller for the two site model than for the
one-site model. Maximum sensitivity will be found when
one uses the maximum possible coating by pre-added
peptide and a minimum amount of added antibody, yet
enough to give an easily measurable signal.
A model that assumes that the peptide binds to the plastic
substrate with at least two modalitiesand at least two dif-
ferent binding affinities for the antibody (the two-site
model) agrees with the experimental findings. According
to this simulation, the peptide molecules that are bound
with the highest affinity and hence are bound first, i.e., at
the lowest concentrations of added peptide, are those to
which the antibody binds with lowest avidity. Thus, as the
amount of bound peptide increases, the half-saturation
concentration of the attached peptide for antibody sub-
stantially decreases (its avidity increases), and the added
free peptide is less able to compete. But this effect is not
very large and four orders of magnitude of increasing
attached peptide raise the Kd for the competing added
peptide by less than 50% (Table 6, section C). On the
other hand, at a fixed amount of attached peptide, raising
the amount of added antibody by a similar four orders of
magnitude raises the Kd for the competing peptide four
fold. Thus, to obtain the highest sensitivity, together with
the highest signal-to-noise ratio, it would appear to be
preferable to reduce as far as possible the concentration of
the antibody and to increase, rather, the amount of bound
peptide.
We believe that this phenomenon of the binding in sev-
eral possible conformations is a universal phenomenon
for binding of small peptides to plastic substratum and we
have to take this into consideration when we design such
an assay.
Nothing in our analysis rules out the possibility that there
is a continuous distribution of affinities between the sub-
stratum and the added peptide in the binding isotherm.
We can only state that at least two classes of sites seem to
be present.
Conclusion
We have conducted a study aimed at the optimization of
the Peptidomatrix and developed a theoretical model that
explains the experimental data. This model takes into
account the interaction of the peptides with the ELISA
plate, the interactions of the antibodies with the bound
and the free peptides and the competition between them.
Methods
Materials
Polyclonal antibodies were custom made by Affinity
Bioreagents (ABR, Golden, CO)
Peptides: Synthetic peptides were obtained by a number
of sources, ABR, Biosight Ltd (Karmiel, Israel) and the
service department of the Hebrew University in Jerusalem
Peptide selection
The peptides on which the ELISA is based are chosen using
a three-fold screening process: First, a list is made of all the
peptides that are likely to be present in a tryptic digest of
Table 4: summary of the results with the different peptides.
A- peptide titration B- serum titration C-competition (peptide titration) D-competition (Antibody titration)
Kp Amax Ka Amax Kd Amax Kd Amax
1 ↓↑↓ ↑ ↑ ↑
2 ↓↑↓ ↑ ↑ ↑
3 ↓↑ ↔ ↑ ↑ ↑
4 ↓↑↓ ↑ ↑ ↑
5 ↓↑↓ ↑
6 ↓↑ ↑ ↑ ↑ ↑
7 ↓↑ ↑↑
8 ↓↑ ↑↑
9 ↓↑ ↑↑
10 ↑↑ ↑ ↑
11 ↓↑ ↑ ↑ ↑ ↑
A-the effect of increasing the amount of antibody.
B- the effect of increasing the amount of attached peptide.
C- the effect of increasing the amount of attached peptide on the parameters of the competition.
D- the effect of increasing the amount of antibody on the parameters of the competition.
(1)MXR P5/#853, (2) MXR P5/#851, (3) MXR P2/#850, (4) MXR P2/#795, (5) MXR P3/#795, (6) MXR P1/#841, (7) ATP P1/#840, (8) ATP P3/#855, 
(9) ATP P4/# 485, (10) MRP P1/#151 #152,(11) MRP P2/#151 & #152Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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the protein to be identified. The sequences of the desired
proteins were retrieved from the NCBI databases. A virtual
"digest" was performed on the sequence using the Micro-
soft Word program. Next, peptides 7–15 amino acid long
were selected. Each peptide from this selection was
checked for its uniqueness amongst all the polypeptide
chains that comprise the human proteome, using the
BLAST program (parameters: PAM 30 Gap Costs Existence
5, Extension 2). From this limited list, we chose the more
hydrophilic peptides as being those that would be most
likely to be good antigens [6,13]. A number of these
selected peptides were ultimately chosen for production
of antibodies, and then used in the protocol described
below
The peptides chosen for this investigation are shown in
Table 1.
Polyclonal antibodies
The polyclonal antibodies used throughout this study
were generated in rabbits by Affinity Bioreagents, Inc.
(ABR, Golden, CO), whole serum was used in all the
experiments. The antigen for immunization was prepared
also by ABR, including the synthesis of the peptides, the
conjugation to a carrier and the injection to rabbits. The
rabbits were bled once before immunization and 3 or 4
times after immunization. The titers were recorded and
the various bleedings kept and used for the development
of the immunoassay.
Competitive ELISA
Maxisorp ELISA plates (NUNC, Denmark) were coated
overnight at 4°C, with 0.1–2 µg/ml of the relevant syn-
thetic peptide in 0.1 M carbonate buffer pH 9.6 and
blocked 2 hours at room temperature with a blocking
buffer containing 3% BSA/0.05 % Tween 20 in phosphate
buffered saline (PBS, 0.1 M phosphate buffer, 150 mM
NaCl, pH 7.2). For the binding experiments the immune
serum was diluted at the desired concentration in block-
ing buffer. For the competition experiments serial binary
dilutions of the synthetic peptide (from 5 to 0.078 µg/ml)
and a blank sample were prepared in blocking buffer con-
taining the desired antibody at the desired concentration.
100 µl of these solutions were added to the wells and
incubated at room temperature 1–3 hours. The wells were
washed 4 times with 1× PBS/0.05% Tween 20 and 100 µl
of horseradish peroxidase(HRP)-conjugated 2nd Ab (anti-
rabbit) diluted 1:10,000 or 1:20,000 in blocking buffer
Table 5: Kinetic parameters obtained by simulating the conditions for the Peptidomatrix using equations A2 and A5 (single binding 
site). Data in Fig 5.
A : increasing attached peptide at four fixed levels of added antibody
Antibody 0.1 Antibody 1 Antibody 10 Antibody 100
Kd 30.00 30.00 30.00 30.00
Amax 0.5 4.55 25.00 45.45
B: increasing added antibody at four fixed levels of attached peptide
Attached peptide 0.1 Attached peptide 1 Attached peptide 10 Attached peptide 100
Kd 100.00 100.00 100.00 100.00
Amax 1.61 12.50 38.46 48.54
C: Competition assay – Kd determined when increasing added free peptide at four fixed levels of attached peptide
Attached peptide 0.1 Attached peptide 1 Attached peptide 10 Attached peptide 100
Kd 1.10 1.10 1.10 1.10
Amax 0.15 1.14 3.5 4.41
D: Competition assay – Kd determined when increasing free peptide at four fixed levels of added antibody
Antibody 0.1 Antibody 1 Antibody 10 Antibody 100
Kd 1.01 1.10 2.00 11.00
Amax 0.12 1.14 6.25 11.36Proteome Science 2006, 4:12 http://www.proteomesci.com/content/4/1/12
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were added in each well. After incubation for one hour at
RT and washing as above, the bound HRP conjugate was
detected by adding 100 µl of tetramethyl benzidine
(TMB). The peroxidase reaction was stopped after 5- min-
utes by the addition of 50 µl 0.5 M H2SO4. Optical densi-
ties at 450 nm were measured using an ELISA reader. The
assay was in triplicates.
Data elaboration
The data from the ELISA plate reader are fed into a data
analysis template in the program Sigmaplot (SPSS, Chi-
cago, IL). A plot of the OD450 vs. the concentration of the
antibody or the concentration of the free peptide is drawn.
The plot is then fitted, using a regression program, to a
hyperbola fitting an ascending (Equation. 1) or a descend-
ing (Equation. 2) hyperbolic 3-parameter equation, as
described in the text:
Equation 1  y
AS
Kd S
D =
∗
+
+
max
Theoretical determination of the optimal conditions for the Peptidomatrix Figure 5
Theoretical determination of the optimal conditions for the Peptidomatrix. (A) Binding of the antibody (at different 
dilutions) to wells containing increasing amounts of peptide,0.1(● ),1(❍ ), 10(▼ ), 100(Ќ). (B) Titration of bound peptide (differ-
ent amounts) with increasing concentrations of antibody, 0.1(● ), 1(❍ ), 10(▼ ), 100(Ќ). (C) Competition between attached and 
free peptide using 4 concentrations of attached peptide,0.1(● ),1(❍ ), 10(▼ ), 100(Ќ), first antibody 'dilution' was 10. (D) Com-
petition between attached and free peptide using 4 concentrations of antibody 0.1(● ),1(❍ ), 10(▼ ), 100(Ќ), 'attached peptide' 
was 10. All these curves are simulations and were drawn using equation A2 (for panel A and B) and A5 (for panel C and D), 
with kinetic parameters of Ka = 30, Kp = 10, cap = 50 and Kf = 1, see the appendix for details. All the data were analyzed using 
the Michaelis-Menten equation (normal and descending hyperbola). The derived values of Kd and Amax appear in table 5.
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Equation 2 
where Amax is the calculated maximal amplitude of the
curve, D the predicted minimum of the ELISA readings,
corresponding essentially to the background signal, S the
concentration of the antibody or the attached peptide (in
equation 1) or the free peptide (in equation 2) and Kd is
the concentration that gives one-half of the shift between
maximum and minimum readings.
Appendix
Derivation of the equations that describe the competition
between bound and free peptide for the appropriate antibody:
The first equation describes the binding between the pep-
tide and the plastic substratum. When an amount P of the
peptide that is to be bound is added to a well having a
maximal binding capacity of cap  and a half-saturation
concentration for this binding of Kp, we obtain for the
amount of bound peptide, BP, according to a simple
hyperbola, the equation.:
The second equation describes the binding, again
described by a hyperbola, between the bound peptide and
the added antibody, where the concentration of free
y
AK m
Kd S
D =
∗
+
+
max
AB P 1 =
∗
+
cap P
Kp P
Theoretical determination of the optimal conditions for the Peptidomatrix ACORDING TO 2 SITES Figure 6
Theoretical determination of the optimal conditions for the Peptidomatrix ACORDING TO 2 SITES. (see the 
appendix for details). Panels A, B, C and D are as described in the legend of Figure 5 except that the equations used in this case 
were A6 (for panel A and B) and A7 (for panel C and D). All data were analyzed using the Michaelis-Menten equation (normal 
and descending hyperbola), using the parameters Ka1 = 30, Ka2 = 3, Kp1 = 10, Kp2 = 100, cap = 50 and Kf = 1. The derived 
values of Kd and Amax appear in table 6.
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added antibody is A, with a half-saturation concentration
for the attached peptide/antibody isotherm of Ka. The
term signal is the ELISA signal obtained, a measure of the
antibody that is bound to the peptide that is itself bound
to the plastic substratum.
To describe the competition between attached and free
peptide we have to use 3 binding parameters. The first and
the second are those we used above to describe the titra-
tion, the third parameter is the affinity between the free
peptide and the free antibody (we assume that the affini-
ties of the antibody for the free and for the attached pep-
tides are different). With a half-saturation concentration
for the free peptide/antibody isotherm of Kf, a concentra-
tion of added free peptide as F, and a concentration TotA
of total antibody, we have (were A is now the concentra-
tion of free added antibody:
Substituting from A3 into A2, we obtain the equation that
describes the competition as:
which follows the Hyperbolic Decay equation on the var-
iable F.
Substituting from A1, and simplifying, we obtain:
The predictions of these equations are given in the Results
section. When we compared these theoretical predictions
with the experimental results, we found a lack of agree-
ment between them. Thus, we explored the possibility
that we have at least 2 sites of binding between the peptide
and the plastic substratum (two different values for Kp),
and, respectively, two different values for Ka. Expanding
Equation A2 and A4 to include the presence of two bind-
ing sites for the peptide to the plastic substratum, and two
affinities for these forms of bound peptide to the anti-
body, we have:
And we obtain for the equation of the competition:
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Reciprocal relationship of peptide-solid support binding and  antibody-peptide binding Figure 7
Reciprocal relationship of peptide-solid support bind-
ing and antibody-peptide binding. Our data indicate that 
when the peptide binds to the plate tightly, with a low Kp, 
the antibodies bind the peptide more loosely, with high Kd. 
And, vice versa, if the peptide is bound loosely, then the anti-
body-peptide bond will be stronger. This figure represents 
schematically a possible mechanism for this phenomenon. 
Panel A: The peptide binds with low affinity, represented 
here with a single attachment point to the solid support. As a 
result the antibody has facilitated access to the peptide and 
the peptide -antibody bond is strong. Panel B: The peptide 
binds tightly, represented here as multiple attachment points. 
In this case the access of the antibodies is hindered by steric 
interference and the antibody-peptide bond is weaker. It is 
worth noting that our results indicate that by changing the 
concentration of the peptide at the time of plating it is possi-
ble to manipulate the strength of the attachment: High con-
centration of the peptide result in low affinity binding while 
low concentrations of the peptide result in high affinity bind-
ing.
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Table 6: Kinetic parameters obtained by simulating the conditions for the Peptidomatrix, using equations A2 and A7 (two binding 
sites). Data in Fig 6.
A: increasing attached peptide at four fixed levels of added antibody
Antibody 0.1 Antibody 1 Antibody 10 Antibody 100
Kd 25.53 25.22 22.69 14.70
Amax 0.52 4.80 27.49 61.77
B: increasing added antibody at four fixed levels of attached peptide
Attached peptide 0.1 Attached peptide 1 Attached peptide 10 Attached peptide 100
Kd 70.55 65.62 43.28 25.68
Amax 1.58 12.28 41.07 69.42
C: Competition assay – Kd determined when increasing added free peptide at four fixed levels of attached peptide
Attached peptide 0.1 Attached peptide 1 Attached peptide 10 Attached peptide 100
Kd 1.3869 1.4333 1.6399 1.8080
Amax 0.2291 1.9375 9.7190 23.5973
D: Competition assay – Kd determined when increasing free peptide at four fixed levels of added antibody
Antibody 0.1 Antibody 1 Antibody 10 Antibody 100
Kd 1.001 1.01 1.64 4.12
Amax 0.16 1.52 9.72 28.98